Susquehanna International Group, LLP 4 D Molecular Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.81 - $27.22 $285,384 - $718,608	-26,400 Reduced 61.54%	16,500 $178,000
Q2 2024 Aug 15, 2024	BUY	$20.93 - $30.01 $441,623 - $633,211	21,100 Added 96.79%	42,900 $900,000
Q1 2024 May 07, 2024	SELL	$17.03 - $35.87 $1.54 Million - $3.24 Million	-90,400 Reduced 80.57%	21,800 $694,000
Q4 2023 Feb 14, 2024	BUY	$9.76 - $21.25 $932,080 - $2.03 Million	95,500 Added 571.86%	112,200 $2.27 Million
Q3 2023 Nov 14, 2023	SELL	$12.64 - $19.76 $5,056 - $7,904	-400 Reduced 2.34%	16,700 $212,000
Q2 2023 Aug 11, 2023	SELL	$15.16 - $23.26 $1.1 Million - $1.69 Million	-72,500 Reduced 80.92%	17,100 $308,000
Q1 2023 May 16, 2023	BUY	$15.45 - $23.19 $852,840 - $1.28 Million	55,200 Added 160.47%	89,600 $1.54 Million
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $235,640 - $875,824	34,400 New	34,400 $764,000

144

57.7M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $286M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.